Iranian
Biomedical Journal
Volume 30, Issue 1 (1-2026)
IBJ 2026, 30(1): 81-89 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Azadian A, Mahmoodzadeh Hosseini H, Mirhosseini S A, Khani S, Amani J. Design and Mode of Action of a New Synthetic Antibacterial Peptide against Pseudomonas aeruginosa. IBJ 2026; 30 (1) :81-89
URL: http://ibj.pasteur.ac.ir/article-1-5380-en.html
URL: http://ibj.pasteur.ac.ir/article-1-5380-en.html
Armineh Azadian 
, Hamideh Mahmoodzadeh Hosseini * , Seyed Ali Mirhosseini , Soghra Khani , Jafar Amani
, Hamideh Mahmoodzadeh Hosseini * , Seyed Ali Mirhosseini , Soghra Khani , Jafar Amani
Abstract:
Background: Research into antimicrobial peptides (AMPs) and other novel antimicrobial strategies continues to be a focus of the scientific community to address the growing challenges posed by antibiotic resistance. The aim of this study was the specific bioinformatic design of a novel hybrid AMP that combines the potent antibacterial properties of Temporins and Brevinin while minimizing its cytotoxic effects.
Methods: The N-terminal of Brevinin peptides and the C-terminal of Temporin peptide were selected. To optimize the peptide, we replaced the amino acids at positions 1, 3, and 7 with glycine, lysine, and lysine, respectively. Various approaches were used to assess physicochemical characteristics, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), cytotoxicity, apoptosis, hemolytic activity, and reactive oxygen species generation.
Results: The novel peptide had 57% hydrophobicity and four positive electric charges due to its lysine amino acid composition. The synthesized peptide exhibited MIC and MBC values of 80 µM against Pseudomonas aeruginosa. According to the MTT assay, the peptide showed neither cytotoxic nor hemolytic effects on human cells. The results of electron microscopy showed that this peptide can disrupt the integrity of P. aeruginosa membrane cells and induce morphological changes in their surface structure.
Conclusion: This research suggests that the synthetic peptide could serve as a promising potential therapeutic agent to combat antibiotic-resistant strains of P. aeruginosa.
Methods: The N-terminal of Brevinin peptides and the C-terminal of Temporin peptide were selected. To optimize the peptide, we replaced the amino acids at positions 1, 3, and 7 with glycine, lysine, and lysine, respectively. Various approaches were used to assess physicochemical characteristics, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), cytotoxicity, apoptosis, hemolytic activity, and reactive oxygen species generation.
Results: The novel peptide had 57% hydrophobicity and four positive electric charges due to its lysine amino acid composition. The synthesized peptide exhibited MIC and MBC values of 80 µM against Pseudomonas aeruginosa. According to the MTT assay, the peptide showed neither cytotoxic nor hemolytic effects on human cells. The results of electron microscopy showed that this peptide can disrupt the integrity of P. aeruginosa membrane cells and induce morphological changes in their surface structure.
Conclusion: This research suggests that the synthetic peptide could serve as a promising potential therapeutic agent to combat antibiotic-resistant strains of P. aeruginosa.
Type of Study: Full Length/Original Article |
Subject:
Related Fields
References
1. Zhang Z, Zhang Q, Wang T, Xu N, Lu T, Hong W, et al. Assessment of global health risk of antibiotic resistance genes. Nat Commun. 2022;13(1):1553. [DOI:10.1038/s41467-022-29283-8]
2. Larsson DGJ, Flach CF. Antibiotic resistance in the environment. Nat Rev Microbiol. 2022;20(5):257-69. [DOI:10.1038/s41579-021-00649-x]
3. Anderson M, Panteli D, van Kessel R, Ljungqvist G, Colombo F, Mossialos E. Challenges and opportunities for incentivising antibiotic research and development in Europe. Lancet Reg Health Eur. 2023;33:100705. [DOI:10.1016/j.lanepe.2023.100705]
4. Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, et al. Pseudomonas aeruginosa: Pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther. 2022;7(1):199. [DOI:10.1038/s41392-022-01056-1]
5. Reynolds D, Kollef M. The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: An update. Drugs. 2021;81(18):2117-31. [DOI:10.1007/s40265-021-01635-6]
6. Gan BH, Gaynord J, Rowe SM, Deingruber T, Spring DR. The multifaceted nature of antimicrobial peptides: Current synthetic chemistry approaches and future directions. Chem Soc Rev. 2021;50(13):7820-80. [DOI:10.1039/D0CS00729C]
7. Huan Y, Kong Q, Mou H, Yi H. Antimicrobial peptides: Classification, design, application and research progress in multiple fields. Front Microbiol. 2020:11:582779. [DOI:10.3389/fmicb.2020.582779]
8. Szymczak P, Możejko M, Grzegorzek T, Jurczak R, Bauer M, Neubauer D, et al. Discovering highly potent antimicrobial peptides with deep generative model HydrAMP. Nat Commun. 2023;14(1):1453. [DOI:10.1038/s41467-023-36994-z]
9. Xuan J, Feng W, Wang J, Wang R, Zhang B, Bo L, et al. Antimicrobial peptides for combating drug-resistant bacterial infections. Drug Resist Updat. 2023;68:100954. [DOI:10.1016/j.drup.2023.100954]
10. Erdem Büyükkiraz M, Kesmen Z. Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds. J Appl Microbiol. 2022;132(3):1573-96. [DOI:10.1111/jam.15314]
11. Lei J, Sun L, Huang S, Zhu C, Li P, He J, et al. The antimicrobial peptides and their potential clinical applications. Am J Transl Res. 2019;11(7):3919-31.
12. Mangoni ML, Casciaro B. Development of antimicrobial peptides from amphibians. Antibiotics (Basel). 2020;9(11):772. [DOI:10.3390/antibiotics9110772]
13. D'Andrea LD, Romanelli A. Temporins: Multifunctional Peptides from Frog Skin. Inter J Molecul Sci. 2023;24(6):5426. [DOI:10.3390/ijms24065426]
14. Tian M, Wang K, Liang Y, Chai J, Wu J, Zhang H, et al. The first Brevinin-1 antimicrobial peptide with LPS-neutralizing and anti-inflammatory activities in vitro and in vivo. Front Microbiol. 2023;14:1102576. [DOI:10.3389/fmicb.2023.1102576]
15. Savelyeva A, Ghavami S, Davoodpour P, Asoodeh A, Los MJ. An overview of Brevinin superfamily: Structure, function and clinical perspectives. Adv Exp Med Biol. 2014:818:197-212. [DOI:10.1007/978-1-4471-6458-6_10]
16. Park CB, Kim HS, Kim SC. Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun. 1998;244(1):253-7. [DOI:10.1006/bbrc.1998.8159]
17. Madanchi H, Akbari S, Shabani AA, Sardari S, Farmahini Farahani Y, Ghavami G, et al. Alignment‐based design and synthesis of new antimicrobial Aurein‐derived peptides with improved activity against Gram‐negative bacteria and evaluation of their toxicity on human cells. Drug Dev Res. 2019;80(1):162-70. [DOI:10.1002/ddr.21503]
18. Khani S, Seyedjavadi SS, Zare-Zardini H, Hosseini HM, Goudarzi M, Khatami S, et al. Isolation and functional characterization of an antifungal hydrophilic peptide, Skh-AMP1, derived from Satureja khuzistanica leaves. Phytochemistry. 2019;164:136-43. [DOI:10.1016/j.phytochem.2019.05.011]
19. Seyedjavadi SS, Razzaghi-Abyaneh M, Bagheri P, Goudarzi M. Antibacterial mechanism of a novel peptide Dendrocin‑ZM1 against Staphylococcus aureus by increasing membrane permeability. Int J Pep Res Ther. 2023;29(6):102. [DOI:10.1007/s10989-023-10577-4]
20. Ning HQ, Li YQ, Tian QW, Wang Z-S, Mo H-Z. The apoptosis of Staphylococcus aureus induced by glycinin basic peptide through ROS oxidative stress response. LWT. 2019;99:62-8. [DOI:10.1016/j.lwt.2018.09.028]
21. Shin JH, Lee Y, Song EJ, Lee D, Jang SY, Byeon HR, et al. Faecalibacterium prausnitzii prevents hepatic damage in a mouse model of NASH induced by a high-fructose high-fat diet. Front Microbiol. 2023;14:1123547. [DOI:10.3389/fmicb.2023.1123547]
22. Luong HX, Thanh TT, Tran TH. Antimicrobial peptides: Advances in development of therapeutic applications. Life Sci. 2020;260:118407 [DOI:10.1016/j.lfs.2020.118407]
23. Klubthawee N, Adisakwattana P, Hanpithakpong W, Somsri S, Aunpad R. A novel, rationally designed, hybrid antimicrobial peptide, inspired by cathelicidin and aurein, exhibits membrane-active mechanisms against Pseudomonas aeruginosa. Sci Rep. 2020;10(1):9117. [DOI:10.1038/s41598-020-65688-5]
24. Madanchi H, Kiasari RE, Seyed Mousavi SJ, Johari B, Shabani AA, Sardari S. Design and synthesis of lipopolysaccharide-binding antimicrobial peptides based on truncated rabbit and human CAP18 peptides and evaluation of their action mechanism. Probiotics Antimicrob Proteins. 2020;12(4):1582-93. [DOI:10.1007/s12602-020-09648-5]
25. Cardoso P, Glossop H, Meikle TG, Aburto-Medina A, Conn CE, Sarojini V, et al. Molecular engineering of antimicrobial peptides: microbial targets, peptide motifs and translation opportunities. Biophys Rev. 2021;13(1):35-69. [DOI:10.1007/s12551-021-00784-y]
26. Zhu X, Shan A, Ma Z, Xu W, Wang J, Chou S, et al. Bactericidal efficiency and modes of action of the novel antimicrobial peptide T9W against Pseudomonas aeruginosa. Antimicrob Agent Chemother. 2015:59(6):3008-3017. [DOI:10.1128/AAC.04830-14]
27. Nishide Y, Nagamine K, Kageyama D, Moriyama M, Futahashi R, Fukatsu T. A new antimicrobial peptide, pentatomicin, from the stinkbug Plautia stali. Sci Rep. 2022;12(1):16503. [DOI:10.1038/s41598-022-20427-w]
28. Yasir M, Dutta D, Willcox MDP. Comparative mode of action of the antimicrobial peptide melimine and its derivative Mel4 against Pseudomonas aeruginosa. Sci Rep. 2019;9(1):7063. [DOI:10.1038/s41598-019-42440-2]
29. Akinwale AD, Parang K, Tiwari RK, Yamaki J. Mechanistic study of antimicrobial effectiveness of cyclic amphipathic peptide [R4W4] against methicillin-resistant Staphylococcus aureus clinical isolates. Antibiotics. 2024;13(6):555. [DOI:10.3390/antibiotics13060555]
30. Vaishampayan A, Grohmann E. Antimicrobials functioning through ROS-mediated mechanisms: Current insights. Microorganisms. 2021;10(1):61. [DOI:10.3390/microorganisms10010061]
31. Strauch S, Briscoe WJ, Doring M, Klempt E, Nikonov VA, Pasyuk E, et al. First measurement of the polarization observable E in the p (γ, π.+.) n reaction up to 2.25 GeV. Phys Lett B. 2015;750:53-8. [DOI:10.1016/j.physletb.2015.08.053]
32. Teixeira V, Feio MJ, Bastos M. Role of lipids in the interaction of antimicrobial peptides with membranes. Prog Lipid Res. 2012;51(2):149-77. [DOI:10.1016/j.plipres.2011.12.005]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |